A new study by Hospital for Special Surgery (HSS) researchers finds that total hip replacement is an excellent option for patients under age 35 with juvenile idiopathic arthritis (JIA) whose joints have been severely damaged by the disease. The findings, presented at the annual meeting of the American College of Rheumatology, reported that hip replacement lasted at least 10 years in 85% of JIA patients.
Juvenile idiopathic arthritis is a common rheumatologic disease in children that often persists into adulthood. It frequently affects the hip joint, and total hip replacement is the standard treatment to relieve pain and restore mobility when nonsurgical treatments no longer help. Despite the observed success of the procedure with younger patients, the study authors noted that the longevity of the implants needs to be improved.
Read more about the findings here.